The National Association of Chain Drug Stores announced on Wednesday that it has written to the Centers for Medicare and Medicaid Services to “recommend administrative changes to facilitate a smooth start for new exchange enrollees seeking prescription drug coverage in the 2015 plan year.”
Medicare’s Annual Wellness Visits present potential opportunities for pharmacists based in physician offices, concluded two experience articles published in the July/August 2014 edition of the Journal of the American Pharmacists Association.
The Office of the National Coordinator for Health Information Technology this fall will launch a consumer outreach campaign Sept. 15 through Oct. 6 to raise awareness around the national Blue Button Initiative, a public-private partnership that seeks to give consumers easy and secure access to their health records from a variety of sources in a format they can use.
Walgreens and Arizona Priority Care have announced a clinical care collaboration agreement to provide coordinated, expanded services for AzPC Medicare Advantage and ACO members through select Walgreens pharmacies and Healthcare Clinics.
The Deparment of Health and Human Services on Wednesday announced the availability of up to $300 million under the Affordable Care Act to help the nation’s community health centers expand service hours, hire more medical providers, and add oral health, behavioral health, pharmacy and vision services.
The Centers for Medicare and Medicaid Services has announced new timing to implement the Medicaid average manufacturer price-based federal upper limits for prescription medications, a move that has been applauded by the National Association of Chain Drug Stores. The FULs were expected to be finalized in July.
Citing the need for a one-year transition period for states to implement the July average manufacturer price-based federal upper limits, or FULs, nine Senators are urging Department of Health and Human Services Secretary Kathleen Sebelius to consider the challenges that states will face when the final Medicaid AMP-based FULs are published.
The National Association of Chain Drug Stores and a national coalition working to achieve “provider status” for pharmacists under Medicare Part B have asked the Federal Trade Commission to back legislation to this effect, as well as other policies that would help pharmacists practice at the top of their education level, NACDS reported Thursday.
Maybelline New York has named Yadim Carranza as the brand's global makeup artist, providing artistic vision for Maybelline New York makeup and becoming the voice of the brand to consumers, press and industry influencers.
Mylan on Friday announced that Supreme Court Chief Justice John Roberts has denied Teva's application for an injunction seeking to prevent Mylan's launch of a generic version of Copaxone (glatiramer acetate injection) pending the Supreme Court's decision on Teva's appeal.
Message to federal health plan payers from community pharmacy: We have the systems in place and the professional expertise to help millions of patients to better their health outcomes at a lower cost. Message to pharmacy from the U.S. Department of Health and Human Services and its Centers for Medicare and Medicaid Services: Prove it.
Bipartisan legislation that would designate pharmacists as healthcare providers under the Medicare program was introduced in the U.S. House of Representatives on Tuesday. The bill would amend The Social Security Act of 1935 to enable pharmacists to work to their full capability by providing underserved patients in the Medicare program with services not currently available to them.
A Medicare proposed rule change limiting the number of prescription drug plans that insurers may offer in the Part D market could require 39% of all enhanced plans to be eliminated in 2016, according to an analysis from Avalere Health that was released Wednesday.
Members of Congress are contacting the U.S. Centers for Medicare and Medicaid Services in support of pro-patient improvements the agency proposed for Medicare Part D prescription drug plans in 2015, a development applauded today by the National Community Pharmacists Association.